Archive for 2004

Biotech execs have a sense of humor about elusive profits

Biotech execs have a sense of humor about elusive profits When Ernst & Young’s annual report on the biotechnology industry last year predicted that as a whole, the industry would turn profitable for the first time in 2008, some long-term industry veterans gave a knowing heard-that-one-before chuckle.


Foresight or folly? Generics firms' foray into NCEs

Foresight or folly? Generics firms’ foray into NCEs A number of generics firms have, over the last few years, veered off the path and started to develop innovative drugs in their own right. In a time when generics firms are showing the greatest growth in the pharmaceutical sector, what has driven them to venture into […]


Foresight or folly? Generics firms’ foray into NCEs

Foresight or folly? Generics firms’ foray into NCEs A number of generics firms have, over the last few years, veered off the path and started to develop innovative drugs in their own right. In a time when generics firms are showing the greatest growth in the pharmaceutical sector, what has driven them to venture into […]


How many trillions for a drug miracle?

How many trillions for a drug miracle? “Here’s a quick thought experiment about the current system for developing and paying for miracle drugs: Would it be worth almost any price to develop a drug with a better than 50-50 probability of conquering many of the world’s most deadly diseases? “


State biotech sector no miracle drug for creation of jobs

State biotech sector no miracle drug for creation of jobs “Ruth Scott’s job is to be the No. 1 cheerleader for biotechnology in Washington state. But when politicians talk up the industry as a silver bullet for job growth, she cringes.”


Do NOT follow this link or you will be banned from the site!
%d bloggers like this: